Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring.
Pfizer said Monday it will pay $48 per share in cash for Array, whose product portfolio includes a treatment combination used for advanced skin cancer that is being tested in other cancers as well....
This article can only be viewed by registered members. Please log in to view it.
Taiger’s solutions use human-like logic to automatically read, understand and extract information, overcoming the limitations of traditional Machine Learning Singapore-based Artificial Intelligence company Taiger today announced it has closed US$25 million in Series B round of funding, led by PacificBridge Asset Management, a Korean and American joint venture affiliated with TPG Capital, and MCM Investment […]
The post Singapore’s AI startup Taiger seals US$25M to expand to Korea, Japan, LatAm appeared first on e27.
Tee Khoon will lead the overall sales function for the country and nurture key industry relationships Singapore-based propertytech group PropertyGuru has announced the appointment of Dr. Tan Tee Khoon as its new Country Manager and inducted him into the executive leadership team. Tee Khoon will lead the overall sales function for Singapore, the group’s flagship […]
The post Dr. Tan Tee Khoon is PropertyGuru’s new Country Manager for Singapore appeared first on e27.
The FIT plans on solidifying its position as the wellness ecosystem leader with the acquisition The FIT Company, Indonesia-based startup that focusses on an active and healthy lifestyle, announced that it has acquired three local startups to further develop the wellness ecosystem in the country. The three startups are Slim Gourmet, Wellnez Indonesia, and FITCO. […]
The post Health and wellness startup The FIT Company acquires three local startups appeared first on e27.